These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 19371895

  • 1. Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
    Beck SD, Foster RS, Bihrle R, Einhorn LH, Donohue JP.
    J Urol; 2009 Jun; 181(6):2526-32. PubMed ID: 19371895
    [Abstract] [Full Text] [Related]

  • 2. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS, Shayegan B, Serio A, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Clin Oncol; 2007 Mar 20; 25(9):1033-7. PubMed ID: 17261854
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
    Eggener SE, Carver BS, Loeb S, Kondagunta GV, Bosl GJ, Sheinfeld J.
    Cancer; 2007 Feb 01; 109(3):528-35. PubMed ID: 17177200
    [Abstract] [Full Text] [Related]

  • 5. Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.
    Carver BS, Bianco FJ, Shayegan B, Vickers A, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Urol; 2006 Jul 01; 176(1):100-3; discussion 103-4. PubMed ID: 16753380
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
    Svatek RS, Spiess PE, Sundi D, Tu SM, Tannir NM, Brown GA, Kamat AM, Wood CG, Pisters LL.
    Cancer; 2009 Mar 15; 115(6):1310-7. PubMed ID: 19156903
    [Abstract] [Full Text] [Related]

  • 8. Growing teratoma syndrome: experience of a single institution.
    Maroto P, Tabernero JM, Villavicencio H, Mesía R, Marcuello E, Solé-Balcells FJ, Sola C, Mora J, Algaba F, Pérez C, León X, López López JJ.
    Eur Urol; 1997 Mar 15; 32(3):305-9. PubMed ID: 9358218
    [Abstract] [Full Text] [Related]

  • 9. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B, Carver BS, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J.
    BJU Int; 2007 May 15; 99(5):993-7. PubMed ID: 17437432
    [Abstract] [Full Text] [Related]

  • 10. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Tal R, Sheinfeld J.
    J Urol; 2006 Nov 15; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
    [Abstract] [Full Text] [Related]

  • 11. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
    Sexton WJ, Wood CG, Kim R, Pisters LL.
    J Urol; 2003 Apr 15; 169(4):1353-6. PubMed ID: 12629359
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF, Winkler M, Savage P, Seckl MJ, Christmas TJ.
    BJU Int; 2007 Oct 15; 100(4):809-12. PubMed ID: 17711512
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
    Medina-Polo J, Martínez-Silva V, Domínguez-Esteban M, de la Rosa-Kehrmann F, Villacampa-Aubá F, Castellano-Gauna D, Díaz-González R.
    Arch Esp Urol; 2011 Sep 15; 64(7):611-9. PubMed ID: 21965259
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL.
    J Urol; 2007 Jan 15; 177(1):131-8. PubMed ID: 17162023
    [Abstract] [Full Text] [Related]

  • 18. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Clin Oncol; 2007 Oct 01; 25(28):4365-9. PubMed ID: 17906201
    [Abstract] [Full Text] [Related]

  • 19. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases.
    Comiter CV, Kibel AS, Richie JP, Nucci MR, Renshaw AA.
    J Urol; 1998 Mar 01; 159(3):859-63. PubMed ID: 9474169
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.